Skip to main content
. Author manuscript; available in PMC: 2015 Jul 6.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Apr;4(4):512–513. doi: 10.1158/1940-6207.CAPR-10-0373

Figure 1.

Figure 1

H+E and MUC5AC Immunohistochemistry on pre and post-Erlotinib pancreatic specimens. IPMN tissue is indicated by the arrow. DUO, normal duodenal epithelium in section.